Influenza vaccines and vaccinations in Poland - past, present and future

Medical Science Monitor

Volumn 18, Issue 11, 2012, Pages

  Brydak, Lidia B ^a,b   Kosek, Agnieszka Woźniak ^a   Nitsch Osuch, Aneta ^c  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY OF SZCZECIN   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Influenza; Poland; Vaccination; Vaccines

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MOLECULAR BIOLOGY; PANDEMIC INFLUENZA; PHARMACY; POLAND; POST EXPOSURE PROPHYLAXIS; REVIEW; SEASONAL INFLUENZA;

EID: 84868591629     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883534     Document Type: Review

References (27)

1. Brydak LB: Influenza, pandemic flu myth or a real threat? Rhythm, Warszawa, 2008; 1-92 [in Polish]
2. www.who.int/influenza/en (avaiable on 12 June 2012)
3. Brydak LB: Influenza disease XXI century. Sepsis, 2010; 3: 301-64 [in Polish]
4. Reid AH, Tauberger JK: The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen, 2003; 85: 2285-92
5. Borchardt RA, Rolston KV: Battling influenza: universal vaccination is the primary weapon. JAAPA, 2012; 25(1): 27-28
6. Cox NJ, Subbarao K: Influenza. Lancet, 1999; 353: 1277-82
7. American Academy of Pediatrics. 2009 Red book. Report of the Committee on Infectious Diseases. 29th ed ELK Grove Village, IL: American Academy of Pediatrics, 2009
8. Kissling E, Valenciano M; I-MOVE Case-Control Studies Team: Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre casecontrol study, 2011/12. Euro Surveill, 2012; 7(15): 20146
9. Joshi AY, Iyer VN, Hartz MF et al: Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: a case-control study. Allergy Asthma Proc, 2012; 33(2): e23-27
10. Janjua NZ, Skowronski DM, De Serres G et al: Estimates of Influenza Vaccine Effectiveness for 2007-2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants. J Infect Dis, 2012; 205(12): 1858-68
11. Marcelin G, Sandbulte MR, Webby RJ: Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. Rev Med Virol, 2012; 22(4): 267-79
12. Lang PO, Mendes A, Socquet J et al: Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging, 2012; 7: 55-64
13. http://www.who.int/influenza/surveillance_monitoring/updates/en/(available 3 July 2012)
14. Reports on cases of infectious diseases and poisonings in Poland, 2010. http://www.pzh.gov.pl/oldpage/epimeld/index_a.html (avaiable 3 July 2012)
15. Reports on cases of infectious diseases and poisonings in Poland, 20111. http://www.pzh.gov.pl/oldpage/epimeld/index_a.html (avaiable 3 July 2012)
16. Reports on cases of infectious diseases and poisonings in Poland, 2008. http://www.pzh.gov.pl/oldpage/epimeld/index_a.html (avaiable 3 July 2012)
17. http://venice.cineca.org/reports.html/(avaiable 2 July 2012)
18. www.ecdc.eu/en/publications/special_reports/Pages/index.aspx (avaiable 1 July 2012)
19. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep, 2011; 60(33): 1128-32
20. Nitsch-Osuch A, Brydak LB, Wardyn AK: Neuraminidase inhibitors in prophylaxis and treatment of influenza]. Pol Merk Lek, 2008; 25(145): 67-73 [in Polish]
21. Wang K, Shun-Shin M, Gill P et al: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev, 2012; 18;4: CD002744
22. Jefferson T, Jones MA, Doshi P et al: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev, 2012; 18: CD008965
23. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Center for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep, 2011/60(RR01); 1-24
24. Ushirogawa H, Ohuchi M: Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus. Virol J, 2011; 8: 411
25. www.emea.europa.eu (available 27 June 2012)
26. Stoner TD, Krauss S, Turner JC et al: Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir. Antiviral Res, 2012; 93(3): 322-29
27. Shetty AK, Peek LA: Peramivir for the treatment of influenza. Expert Rev Anti Infect Ther, 2012; 10(2): 123-43